Stephens & Co. Initiates Coverage On Exelixis with Equal-Weight Rating, Announces Price Target of $23
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Sudan Loganathan initiates coverage on Exelixis (NASDAQ:EXEL) with an Equal-Weight rating and a price target of $23.
May 14, 2024 | 1:34 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Stephens & Co. initiated coverage on Exelixis with an Equal-Weight rating and a price target of $23, potentially influencing investor perception and stock performance.
The initiation of coverage by Stephens & Co. with an Equal-Weight rating and a specific price target provides new information that could influence investor perception. However, the Equal-Weight rating suggests a neutral outlook, which might not significantly impact the stock's short-term movement. The price target of $23 offers a reference point for valuation but does not imply a strong bullish or bearish stance.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100